Omeros Corporation
OMER
#6929
Rank
ยฃ0.51 B
Marketcap
ยฃ7.12
Share price
-1.04%
Change (1 day)
164.53%
Change (1 year)

Revenue for Omeros Corporation (OMER)

Revenue in 2026 (TTM): ยฃ7.47 Million

According to Omeros Corporation's latest financial reports the company's current revenue (TTM ) is ยฃ7.39 Million. In 2025 the company made a revenue of N/A a decrease over the revenue in the year 2024 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Omeros Corporation from 2009 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) ยฃ7.47 M
2025 N/A
2024 N/A
2023 N/A
2022 N/A-100%
2021 -ยฃ59.19 Million-209.29%
2020 ยฃ54.15 M-36.49%
2019 ยฃ85.26 M262.37%
2018 ยฃ23.52 M-50.95%
2017 ยฃ47.96 M42.21%
2016 ยฃ33.72 M269.99%
2015 ยฃ9.11 M2533.13%
2014 ยฃ0.34 M-64.31%
2013 ยฃ0.96 M-73.97%
2012 ยฃ3.72 M28.01%
2011 ยฃ2.91 M113.45%
2010 ยฃ1.36 M52.81%
2009 ยฃ0.89 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
ยฃ72.00 B 973,942.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ47.31 B 639,887.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
ยฃ12.77 M 72.88%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Eterna Therapeutics
ERNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA